Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting
Results Presented in Late-Breaking Abstract as an Oral PresentationPresentation Will Also be Published in the Highlights from CHEST Special EditionWARREN, […]